Atrial Fibrillation Trial, Recruiting NCT06903845 Sponsor: Dong-Ju Choi Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06903845
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 19 years old or older and have been diagnosed with atrial fibrillation (an irregular heartbeat condition)
  • You have at least one of the following health conditions: heart failure, high blood pressure, coronary artery disease (blocked arteries in the heart), peripheral arterial disease (blocked arteries in the legs or arms), diabetes, a history of stroke, or another heart condition that requires treatment
  • You are currently taking, or are planning to start taking, a blood-thinning medication called apixaban (taken by mouth)
  • You are able to use a smartphone that runs on the Android operating system
  • You are willing and able to sign a consent form after being fully informed about the trial's purpose, steps, and possible risks

Who may not be able to join:

  • Your kidneys are working at a very low level (specifically, your creatinine clearance is below 15 mL/min — confirm with trial site if unsure what this means for you)
  • You have a moderate to severe narrowing of one of your heart valves called the mitral valve
  • You have previously had your mitral heart valve repaired or replaced
  • You have a significant history of problems with alcohol or drug misuse
  • The trial doctor has decided, for legal or psychological reasons, that the trial may not be appropriate for you
  • You have taken part in another clinical trial involving an experimental drug in the last 4 weeks before being assessed for this trial
  • You are unwilling or decline to sign the consent form to take part in this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dong-Ju Choi
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
31 December 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Medication adherence by pill count

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov